KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to KYV-101
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.